Lipoprotein Lipase Gene Polymorphisms and the Risk of Target Vessel Revascularization After Percutaneous Coronary Intervention
Pascalle S. Monraats, MSc*, ,
Jamal S. Rana, MD ,
Melchior C. Nierman, MD ,
Nuno M.M. Pires, MSc*, ,
Aeilko H. Zwinderman, PhD||,
John J.P. Kastelein, MD, PhD ,
Jan Albert Kuivenhoven, PhD ,
Moniek P.M. de Maat, PhD¶,
Saskia Z.H. Rittersma, MD#,
Abbey Schepers, MD ,**,
Pieter A.F. Doevendans, MD, PhD ,
Robbert J. de Winter, MD, PhD#,
René A. Tio, MD, PhD ,
Rune R. Frants, PhD ,
Paul H.A. Quax, PhD ,**,
Arnoud van Der Laarse, PhD*,
Ernst E. van Der Wall, MD, PhD* and
J. Wouter Jukema, MD, PhD*, ,*
* Department of Cardiology, Leiden University Medical Center, Leiden
Interuniversity Cardiology Institute of the Netherlands (ICIN), Utrecht
Department of Vascular Medicine, Academic Medical Center, Amsterdam
Gaubius Laboratory, TNO-Quality of Life, Leiden
|| Department of Medical Statistics, Academic Medical Center, Amsterdam
¶ Department of Hematology, Erasmus University Medical Center, Rotterdam
# Department of Cardiology, Academic Medical Center, Amsterdam
** Department of Surgery, Leiden University Medical Center, Leiden
 Department of Cardiology, University Medical Center, Utrecht
 Department of Cardiology, Academic Hospital, Groningen
 Department of Human Genetics, Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands

View larger version (9K):
[in a new window]
|
Figure 1 Messenger ribonucleic acid (mRNA) expression of lipoprotein lipase in a cuffed femoral artery (as compared with hypoxathine-guanine phosphoribosyl transferase mRNA expression, cuff vs. normal artery).
|
|
|